Criteria for use of pancuronium bromide, vecuronium bromide, atracurium besylate, tubocurarine chloride, metocurine iodide, pipecuronium bromide, and doxacurium chloride in adults

Affiliations

Comparative Study

A J Donnelly et al. Clin Pharm. 1992 May.

. 1992 May;11(5):435-41.

¹ Department of Pharmacy, Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL.

No abstract available

Similar articles

Clinical relaxation: current controversy.
Savarese JJ. Savarese JJ. Can Anaesth Soc J. 1986 May;33(3 Pt 2):S1-4. doi: 10.1007/BF03019148. Can Anaesth Soc J. 1986. PMID: 2872951 Review. No abstract available.
Interaction between nondepolarizing neuromuscular blocking agents and inhalational anesthetics.
Swen J, Rashkovsky OM, Ket JM, Koot HW, Hermans J, Agoston S. Swen J, et al. Anesth Analg. 1989 Dec;69(6):752-5. Anesth Analg. 1989. PMID: 2574015
Clinical experiences with pipecuronium bromide.
Boros M, Szenohradszky J, Kertész A, Marosi G, Tutsek L. Boros M, et al. Acta Chir Hung. 1983;24(4):207-14. Acta Chir Hung. 1983. PMID: 6322488
Comparative evaluation of the neuromuscular and cardiovascular effects of pipecuronium, pancuronium, atracurium, and vecuronium under isoflurane anesthesia.
Larijani GE, Gratz I, Minassian SS, Hughes DL, Afshar M, Karayannis BN. Larijani GE, et al. Pharmacotherapy. 1992;12(4):278-82. Pharmacotherapy. 1992. PMID: 1355599 Clinical Trial.
Newer neuromuscular blocking drugs. An overview of their clinical pharmacology and therapeutic use.
Mirakhur RK. Mirakhur RK. Drugs. 1992 Aug;44(2):182-99. doi: 10.2165/00003495-199244020-00003. Drugs. 1992. PMID: 1382013 Review.